Business Segments · Restructuring Charges
Prescription Technology Solutions — Restructuring Charges
Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00. Over 2 years (FY 2022 to FY 2024), Prescription Technology Solutions — Restructuring Charges shows a downward trend with a -33.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ3 2019
Last reportedQ3 2025
Rolls up toRestructuring Charges
How to read this metric
High charges indicate aggressive transformation efforts, which may lead to future margin expansion if successful.
Detailed definition
Aggregates all costs associated with formal restructuring programs designed to improve the profitability and operational...
Peer comparison
Widely used metric across the industry to track the cost of corporate transformation and efficiency programs.
Metric ID:
mck_segment_prescription_technology_solutions_restructuring_chargesHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.00M | $0.00 | $0.00 | $10.00M | $7.00M | $7.00M | $1.00M | $36.00M | $2.00M | $3.00M | $2.00M | $6.00M | $4.00M | $1.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — | -30.0% | +0.0% | -85.7% | >999% | -94.4% | +50.0% | -33.3% | +200.0% | -33.3% | -75.0% | -100.0% | — | — |
| YoY Change | — | — | — | — | -61.1% | — | — | +260.0% | -71.4% | -57.1% | +100.0% | -83.3% | +100.0% | -66.7% | -100.0% | -100.0% | -100.0% |
Range$0.00 – $36.00M
CAGR-100.0%
Avg YoY Growth-16.3%
Median YoY Growth-66.7%
Current Streak5 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — restructuring charges?
- McKesson (MCK) reported prescription technology solutions — restructuring charges of $0.00 in Q3 2025.
- How has McKesson's prescription technology solutions — restructuring charges changed year-over-year?
- McKesson's prescription technology solutions — restructuring charges decreased by 100.0% year-over-year, from $1.00M to $0.00.
- What is the long-term trend for McKesson's prescription technology solutions — restructuring charges?
- Over 2 years (2022 to 2024), McKesson's prescription technology solutions — restructuring charges has grown at a -33.7% compound annual growth rate (CAGR), from $25.00M to $11.00M.
- What does prescription technology solutions — restructuring charges mean?
- Total expenses related to organizational restructuring programs within the technology solutions segment.